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Glucocorticoid receptor (GR) and related steroid hormone receptors are ligand-dependent transcription factors
whose regulation is critical for both homeostasis and diseases.The structural maturation of the GR has been
shown to require the Hsp90 molecular chaperone complex. Evidence indicates that Hsp90-dependent maturation
is critical for GR ligand binding capacity and activity.While the role for Hsp90 in GR function is well established,
the regulation of this process is not well understood. Here we discuss a recent finding that identifies reversible
protein acetylation controlled by the deacetylase HDAC6 as a novel mechanism that regulates Hsp90-dependent
GR maturation.We will also speculate on the implications of this finding in steroid hormone signaling,
oncogenic transformation and its potential therapeutic utility.
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Introduction
Steroid hormone receptors mediate hormone signaling
by acting as ligand dependent transcription factors. Upon
ligand binding, these receptors undergo conformational
changes that are coupled with specific interactions with
transcriptional co-factors and/or nuclear translocation,
culminating with induction of specific transcriptional
programs that control diverse processes from
homeostasis and growth, to reproduction, development
and metabolism [Robinson-Rechavi et al., 2003;
Gronemeyer et al., 2004] . Although ligand binding is the
primary regulatory signal for receptor activation, selected
members of the steroid hormone receptor family require
additional cellular machinery to achieve a conformation
capable of responding to ligand. Extensive biochemical
reconstitution and functional analysis of glucocorticoid
receptor (GR) have revealed an obligatory role for the
molecular chaperone Hsp90 in GR structural maturation
and function [Pratt et al., 1992; Pratt et al., 1992] . It has
been proposed that GR is normally associated with the
Hsp90 chaperone complex in the cytoplasm prior to ligand
binding.This association allows GR to achieve a structural
conformation that is competent for ligand binding, nuclear
translocation and consequently, gene regulation.This
view is supported by the observation that treating cells
with the Hsp90 inhibitor geldanamycin can effectively
suppress GR ligand binding and transcriptional activity
[Tago et al., 2004] . However, the critical issue as to
whether the Hsp90-GR functional interaction is regulated
and what mechanisms are involved has not yet been
addressed. Our recent characterization of Hsp90
acetylation may have provided an answer to this important
question.
In a search for proteins that associate with the
microtubule-associated cytoplasmic deacetylase HDAC6
[Hubbert et al., 2002] , we identified Hsp90 as a substrate
for HDAC6.We found that HDAC6 can deacetylate Hsp90
both in vitro and in vivo. Inactivation of HDAC6 leads to
the accumulation of acetylated Hsp90, which is
accompanied by a failure of Hsp90 to form a stable
complex with GR, or with the critical co-chaperone p23.
This results in GR that is defective in ligand binding,
nuclear translocation and transcriptional activity.These
findings provide experimental evidence that the
Hsp90-GR interaction and, consequently the structural
maturation of GR are indeed subject to regulation by
acetylation, and implicates HDAC6-mediated
deacetylation of molecular chaperones as a potential
novel mechanism that impinges on steroid hormone
signaling [Kovacs et al., 2005] .
Hsp90 - more than a stress protein
For a number of years Hsp90 has been perceived as a
stress-induced protein with a more general housekeeping
function. A very different picture, however, has recently
started to emerge. Hsp90 and its co-factors, termed
co-chaperones, form molecular chaperone complexes
that facilitate the structural maturation of its substrates,
termed client proteins.The Hsp90-assisted maturation
of client proteins often leads to an enhanced activity and
stability for these client proteins [Pratt and Toft, 2003] .
The characterization of Hsp90 client proteins led to a
surprising realization that, instead of proteins with
housekeeping functions, many Hsp90 client proteins are
critical for cell signaling, including oncogenic kinases such
as ErbB2 Akt, Raf and Bcr-Abl and the aforementioned
glucocorticoid receptor [Pratt, 1997] . Supporting the
importance of Hsp90 in cell signaling, Hsp90 inhibitors,
such as geldanamycin, display potent biological effects,
and can induce growth arrest and apoptosis in tumor cell
lines [Blagosklonny et al., 2001] .The emerging
significance of Hsp90 in both normal and oncogenic
signaling highlights the need to understand how Hsp90
is regulated, The characterization of the HDAC6-Hsp90
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regulatory mechanism for Hsp90 activity.
Got acetylation? It’s not just for
histones and chromatin anymore
Traditionally post-translational modification by acetylation
has been linked to histone and chromatin-dependent
processes. Recent evidence, however, strongly suggests
that reversible acetylation can regulate important
biological processes independent of chromatin [Cohen
and Yao, 2004] . For example, the characterization of
HDAC6 has implicated protein acetylation in the regulation
of microtubule dynamics, growth factor-induced
chemotaxis and the processing of misfolded protein
aggregates [Hubbert et al., 2002; Haggarty et al., 2003]
. Consistent with these apparently non-genomic functions,
HDAC6 is mainly localized to the cytoplasm where it
dynamically associates with cytoskeleton. Accordingly,
identifying substrates for HDAC6 would be critical to
decipher how HDACs might regulate non-chromatin
related processes. In a search for such targets, we
identified Hsp90 as a substrate for HDAC6 [Kovacs et
al., 2005] . Although it remains unclear whether Hsp90
also serves as a critical mediator for the established
functions of HDAC6 in cell motility and aggresome
formation, acetylation of Hsp90, induced by inhibiting
HDAC6 via specific siRNA or through the use of an
inhibitor Trichostatin A (TSA), clearly reduces GR activity.
This is particularly interesting as recent reports also found
that TSA treatment inhibits glucocorticoid-mediated
transcriptional activity [Ito et al., 2004] .This inhibition is,
however, unexpected as TSA treatment often activates
gene transcription nonspecifically by inducing histone
hyperacetylation. Our results help to reconcile these
observations and point to an effect of TSA on cytoplasmic
HDAC6 rather than on histones or chromatin. In the
presence of TSA, Hsp90 is unable to properly bind GR,
thus affecting the ability of GR to illicit a transcriptional
response. Importantly, these findings also indicate that
Hsp90-mediated GR maturation is not simply a
constitutive or housekeeping process; rather, it can be
regulated through Hsp90 acetylation, providing another
level of regulation in steroid hormone signaling.
Other nuclear receptors and client
proteins?
The relationship that we have characterized between
reversible acetylation and GR signaling begs a series of
interesting questions. One prevalent question is whether
or not other steroid hormone receptors are subjected to
the same regulation. Evidence indicates that AR, ER, and
PR [Fang et al., 1996; Knoblauch and Garabedian, 1999;
Kosano et al., 1998] all form complexes with Hsp90.The
Hsp90 inhibitor geldanamycin (GA) has been reported to
inhibit the activity of AR, GR, and PR [Solit et al., 2002;
Tago et al., 2004; Smith et al., 1995] . If these receptors
indeed require Hsp90 for full activity, HDAC6 might turn
out to be an important modulator for more than just one
steroid hormone receptor. Similarly, given that several
prominent Hsp90 client proteins are intimately linked to
human cancer [Neckers and Neckers, 2005] , it would be
of great interest to investigate whether Hsp90 acetylation
is also important for the maturation and activity of these
oncoproteins.The answer to these questions not only
would determine whether Hsp90 acetylation plays a more
general role in regulating chaperone activity toward a
broad spectrum of client proteins, but also point to a
potential cancer therapeutic approach through the
suppression of Hsp90 deacetylation.
Regulation of Hsp90 acetylation and cell
signaling
Hsp90 appears to become transiently acetylated upon
GR activation after ligand stimulation. Although the exact
nature of this ligand-induced acetylation remains to be
characterized, it is tantalizing to speculate that acetylation
might be coupled with the maturation of GR. For example,
Hsp90 acetylation might allow the conversion of
GR-Hsp90 from a stable complex into a dynamic one by
dissociating p23 from the Hsp90 complex, thereby
enabling GR to enter the nucleus for transcriptional
activation. As acetylated Hsp90 appears to have reduced
binding toward GR and p23, the subsequent deacetylation
by HDAC6 would then allow Hsp90 to re-enter the
productive chaperone complex (Figure 1). Interestingly,
it appears that certain cellular stresses, such as those
associated with the transformation from normal to
oncogenic state, can also cause Hsp90 chaperone
complex remodeling [Kamal et al., 2004] .We speculate
that acetylation of molecular chaperones might play a
role in the dynamic reorganization of chaperone
complexes in response to such “oncogenic stress”.We
suspect that oncogenic stress, which might be induced
by high demand for “growth and proliferation”-associated
signaling, may lead to a spike in the levels of acetylated
Hsp90 due to an increase in Hsp90-client proteins during
robust cellular growth. Under this scenario, HDAC6 may
then be required for robust Hsp90 activity by regenerating
deacetylated Hsp90 and thereby ensuring effective cell
signaling.This model would also argue that HDAC6 might
play a more important role for cells under specific stress
conditions, such as oncogenic transformation induced by
Hsp90 client proteins.
Therapeutic implications
Steroid hormone receptors are critical for normal
development and homeostasis. Over-expression or
misregulation of receptors and their signaling pathways,
however, can lead to a myriad of disease states. For
example, aberrant glucocorticoid levels have been
associated with muscle atrophy including disuse atrophy
and cachexia, a disorder characterized by muscle wasting
and malnutrition [Hasselgren, 1999] . Indeed, increased
levels of GR signaling can induce muscle atrophy,
possibly through activation of Foxo transcription factors
and the atrophy-related ubiquitin ligases MaFbx and
MuRF1, which are involved in the increase of cellular
proteolysis associated with muscle atrophy [Bodine et
al., 2001; Glass, 2003] . In the case of AR and ER, it is
well documented that mutations and over-expression of
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Perspective Role of acetylation in NR signalingFigure 1. HDAC6-mediated reversible acetylation of Hsp90 and nuclear receptor signaling, a speculative model. Reversible acetylation may
regulate the recycling of Hsp90 in and out of functional chaperone complexes.The deacetylation of Hsp90 allows for the recruitment and binding of
co-chaperones such as p23, and may allow for the recruitment of other co-chaperones (Y and Z) such as p50, Hop, immunophilins, etc (1).The formation
of this chaperone complex facilitates folding of GR that is competent for ligand binding (red receptor), translocation into the nucleus and transcriptional
activation. Ligand binding destabilizes the GR-Hsp90 chaperone complex interaction (2) and induces Hsp90 acetylation by the induction or activation
of the Chaperone Acetyltransferase (CHAT; (3)).The CHAT may also be activated in response to other cellular stresses or “oncogenic stress”(3).
Acetylated Hsp90, which has a reduced affinity for p23 and possibly for other co-chaperones (4), may further destabilize the GR-Hsp90 interaction,
allowing for the nuclear translocation of GR and subsequent transcriptional activation (5). Note that binding of certain co-chaperones may be insensitive
to the acetylation status of Hsp90 (Z). Acetylated Hsp90 is then deacetylated by HDAC6 (6), regenerating Hsp90 that is competent for co-chaperone(s)
complex assembly (7), productive chaperone cycles, and associating with inactive GR (Pink) exported from the nucleus (8). Inactivation of HDAC6 by
TSA, Tubacin or specific siRNA would inhibit the regeneration of deacetylated Hsp90 required for GR or selected client protein maturation (9).
AR are associated with prostate cancer [Rahman et al.,
2004; Suzuki et al., 2003] while ER has been intimately
linked to both the progression and metastasis of breast
cancer [Osborne and Schiff, 2005] . If Hsp90 acetylation
plays an important role in GR, AR and/or ER signaling,
it is conceivable that pharmacological manipulation of
Hsp90 acetylation could represent a critical therapeutic
strategy to abrogate aberrant steroid receptor signaling.
The development of selective high affinity inhibitors similar
to tubacin [Haggarty et al., 2003] may allow for an
attenuation of oncogenic signaling while allowing Hsp90
to manage house keeping cellular activities.
Conclusion
The dynamic Hsp90 acetylation in glucocorticoid receptor
function has revealed another level of regulation in steroid
hormone signaling. Many important questions are to be
answered. For example, how does acetylation regulate
Hsp90 function? Does acetylation affect the structure,
conformation or ATPase activity of Hsp90? Recent
evidence has come forth to suggest that acetylation of
Hsp90 effects ATP binding [Murphy et al., 2005] , which
could certainly affect Hsp90 activity.What is the identity
of the Chaperone Acetyltransferase (which we have
dubbed CHAT)? Is HDAC6 the only Hsp90 deacetylase?
How is Hsp90 acetylation regulated by selective cell
signaling? Is the entire population or only a selected pool
of Hsp90 subject to the regulation by reversible
acetylation? Are there other components of the chaperone
complex regulated by reversible acetylation? By
elucidating the functional relationship between acetylation
and chaperone-mediated signaling in various cellular
processes, we may go a long way towards understanding
how we might use these mechanisms to our own
advantage to battle everything from cancer to muscle
atrophy.The dynamic Hsp90 acetylation in glucocorticoid
receptor function has revealed another level of regulation
in steroid hormone signaling. Many important questions
are to be answered. For example, how does acetylation
regulate Hsp90 function? Does acetylation affect the
structure, conformation or ATPase activity of Hsp90?
Recent evidence has come forth to suggest that
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2005] , which could certainly affect Hsp90 activity.What
is the identity of the Chaperone Acetyltransferase (which
we have dubbed CHAT)? Is HDAC6 the only Hsp90
deacetylase? How is Hsp90 acetylation regulated by
selective cell signaling? Is the entire population or only
a selected pool of Hsp90 subject to the regulation by
reversible acetylation? Are there other components of
the chaperone complex regulated by reversible
acetylation? By elucidating the functional relationship
between acetylation and chaperone-mediated signaling
in various cellular processes, we may go a long way
towards understanding how we might use these
mechanisms to our own advantage to battle everything
from cancer to muscle atrophy.
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